Skip to main content
Psych Congress 2023 Main banner

Full Schedule

Full Schedule

  • Wednesday, September 6, 2023
  • 7:45 AM – 8:45 AM CT
    Orientation Session (non-accredited)
  • 9:00 AM – 12:00 PM CT
    Advanced Psychopharmacology Preconference

    Speaker: Charles L. Raison, MD – University of Wisconsin-Madison

    Speaker: Jonathan M. Meyer, MD – University of California, San Diego

    Speaker: Steven R. Chan, MD, MBA – Stanford University School of Medicine, Stanford, California

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    Speaker: Vladimir Maletic, MD – University of South Carolina School of Medicine Greenville

    This year’s advanced psychopharmacology preconference is designed to give an overview of the “four most exciting things happening in Psychiatry”. You will leave this pre-conference energized and ready to take on the next 4 days of continued psychopharmacology education, one step ahead of your peers.

    Click to Read More

    Depressive Disorders

    Psychedelics

    Psychotic Disorders

    Technology

  • 9:00 AM – 12:00 PM CT
    Introduction to Reproductive Psychiatry and Perinatal Mental Health Preconference

    Speaker: Rachel Dalthorp, MD, MHSA – LifeStance Health

    Speaker: Melanie Barrett, MD – International Society of Reproductive Psychiatry

    Speaker: Danielle J. Johnson, MD, FAPA – International Society of Reproductive Psychiatry

    Speaker: Gillian S. Friedman, MD, board-certified in psychiatry and addiction medicine – California Dept of State Hospitals - Patton State Hospital

    Speaker: Nichelle Haynes, DO – International Society of Reproductive Psychiatry, Reproductive Psychiatry and Counseling

    Speaker: Craig Chepke, MD, DFAPA – Excel Psychiatric Associates

    Speaker: Nicole H. Cirino, MD, CST, IF, PMH-C – Baylor College of Medicine

    This year’s preconference is designed to give an overview of reproductive psychiatry, developed in partnership with the International Society for Reproductive Psychiatry (ISRP). You will leave this pre-conference with an expanded knowledge of women’s health and reproductive psychiatry throughout the lifespan.

    Click to Read More

    Women's Mental Health

  • 12:15 PM – 1:30 PM CT
    A nonstimulant that works for ADHD

    Innovation Theater

  • 12:15 PM – 1:30 PM CT
    Bridging the Gap: Health Equity and Barriers in Patients Living With BP-I Disorder

    Innovation Theater

  • 12:15 PM – 1:30 PM CT
    Deplin® as Early Adjunctive Therapy in Major Depressive Disorder

    Innovation Theater

  • 12:15 PM – 1:30 PM CT
    Forging a New Path: ​Targeting Muscarinic Receptor Circuits in Schizophrenia

    Innovation Theater

  • 1:45 PM – 3:15 PM CT
    Welcome Session Featuring Kay Redfield Jamison

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    Speaker: Julie A. Carbray, PhD, APRN – University of Illinois Chicago

    Speaker: Greg Mattingly, MD – St.Charles Psychiatric Associates

    Speaker: Kay Redfield Jamison, PhD – Johns Hopkins Medicine

    Speaker: Jennifer S. Mascaro, PhD – Emory University School of Medicine

    Speaker: Michael Pollock – Depression and Bipolar Support Alliance

    The co-chairs of the 36th annual Psych Congress will commence the conference by introducing two remarkable presentations and priming attendees for an engaging and informative week ahead.

    Dr. Jennifer Mascaro will explore the powerful relationship between language, treatment adherence and patient outcomes, highlighting the critical importance of using inclusive language and avoiding stigmatizing terms in clinical settings to promote better health outcomes and patient satisfaction.

    Join Dr. Kay Redfield Jamison, internationally renowned clinical psychologist, and award-winning author with lived experience, as she delves into the enduring foundations of psychotherapy and explores the essential traits of effective healers.

    Developed in partnership with Depression and Bipolar Support Alliance

    Psych Congress has partnered with the Depression and Bipolar Support Alliance to deliver advanced education on mood disorders including Depression and Bipolar Disorder, which affect over 21 million Americans and account for over 50% of the nation’s suicides every year.
  • 3:30 PM – 4:45 PM CT
    Comfort or Control? Defining a Good Death Within the Clinical and Legal Landscapes

    Speaker: W Clay Jackson, MD, DipTh – University of TN College of Medicine

    This session will explore the complex landscape of end-of-life care and the debate surrounding the values of autonomy and comfort. The presentation will delve into how language, such as euthanasia and medical aid in dying, shapes the clinical and political realities of end-of-life care, and how this framing impacts patient and family decision-making. The session will also address the primary concerns of those who oppose the determination of the timing of death and distinguish among palliative sedation, euthanasia, and physician-assisted suicide. Attendees will leave with a deeper understanding of how to navigate the legal and ethical considerations of end-of-life care, with a focus on defining what constitutes a "good death."
  • 3:30 PM – 4:45 PM CT
    Expert Panel: Has the Pendulum Swung Too Far? Challenging the Stigma with Benzodiazepines

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    Speaker: Saundra Jain, MA, PsyD, LPC – Private Practice, Austin, Texas

    Speaker: Lydia Anne M. Bartholow, DNP, PMHNP, CARN-AP – Central City Concern

    Speaker: Vanessa Walker

    While benzodiazepines can be highly effective in managing symptoms, they are often viewed as addictive and dangerous, leading many patients to avoid seeking treatment altogether. This session will explore the stigma associated with the use of benzodiazepines in the treatment of anxiety and other mental health disorders.

    Click to Read More

    Anxiety Disorders

    Addiction & Substance Use Disorders

  • 3:30 PM – 4:45 PM CT
    Foundations in Psychopharmacology: Focus on Antidepressants

    Speaker: Michael E. Thase, MD – Perelman School of Medicine at the University of Pennsylvania SOM

    A new feature at Psych Congress in 2023, each Foundations in Psychopharmacology session will dive deep into one specific therapeutic drug class, such as antidepressants or antipsychotics. These sessions are distinct in their foundational emphasis on both long-standing medications often appropriate as first-line therapies, as well as additional first-line options and adjunctive treatments. Foundations sessions may be particularly valuable for early-career psychopharmacologists and those looking for a detailed look at the when and the why of medication selection as well as access-related challenges and considerations that may affect treatment decisions.

    Click to Read More

    Foundations

    Depressive Disorders

  • 3:30 PM – 4:45 PM CT
    Prolonged Grief after Suicide Loss: Treatments Restore Hope

    Speaker: Sidney Zisook, MD – UC San Diego

    The phenomenon of prolonged grief after suicide loss is a significant and often debilitating challenge for many individuals and families. In this session we will explore the latest research and innovative treatments for addressing this complex and multifaceted issue. Through a focus on restoring hope and promoting healing, we will discuss how to effectively support those who are struggling with prolonged grief after suicide loss and empower them to move forward with resilience and optimism.

    Developed in partnership with the American Foundation for Suicide Prevention.

    Suicide Prevention

    Trauma

  • 3:30 PM – 4:45 PM CT
    Understanding and Managing Agitation in Psychiatric Disorders

    Speaker: Leslie L. Citrome, MD, MPH – Department of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY

    In this session, we will explore the underlying mechanisms of agitation and how it manifests in different psychiatric disorders, with a focus on schizophrenia and bipolar disorder. We will discuss evidence-based interventions for managing agitation, including pharmacotherapy and psychotherapeutic approaches. Attendees will gain a deeper understanding of the impact of agitation on patients and learn practical strategies for effectively managing agitation in psychiatric practice.
  • 5:00 PM – 6:15 PM CT
    Harnessing the Power of Neuroplasticity in MDD: The Evolving Role of Digital Therapeutics

    Speaker: Saundra Jain, MA, PsyD, LPC – Private Practice, Austin, Texas

    Speaker: Steven R. Chan, MD, MBA – Stanford University School of Medicine, Stanford, California

    Speaker: Desiree Matthews, PMHNP-BC – Different MHP, PC

    Join us for an engaging MasterClass educational session designed to equip medical professionals with the latest insights and practical skills for enhancing the management of major depressive disorder (MDD). Expert faculty will discuss the of the role of neuroplasticity in MDD and its implications for disease management, particularly in relation to digital therapeutics. Dive into the interpretation of the most recent clinical data for digital therapeutic strategies in the context of MDD, and learn about their efficacy to cognitive behavioral therapy. Additionally, participants will learn how to implement strategies that address barriers to the integration of digital therapeutics into clinical practice. By the end of the session, attendees will have the tools to optimize MDD management, incorporating cutting-edge approaches and overcoming obstacles. Don't miss this opportunity to enhance your understanding of MDD treatment and improve patient outcomes.

    Click to Read More

    Master Class

  • 5:00 PM – 6:15 PM CT
    Improving Outcomes in MDD: Shining a Light on Glutamatergic Therapies

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    Speaker: Maria Margaglione – Not applicable

    The management of major depressive disorder (MDD) is an ongoing clinical challenge, especially considering the large proportion of patients who experience an inadequate response to initial antidepressant monotherapy. These patients experience a substantial burden with higher functional impairments and poorer clinical outcomes. In this MasterClass session, expert faculty will delve into the assessment of the prevalence and burden of poor response in individuals with MDD, exploring the limitations of traditional antidepressants that often contribute to this issue, offering insights into the factors underlying poor response. Participants will gain a profound understanding of the role of glutamatergic signaling in the pathophysiology of MDD and how this knowledge translates into potential therapeutic targets. Expert faculty will critically evaluate the mechanisms of action, pharmacokinetic profiles, and the latest clinical data associated with newer and emerging glutamatergic pharmacotherapies.

    Click to Read More

    Master Class

  • 5:00 PM – 6:15 PM CT
    Putting it All Together in Bipolar Disorder: Novel Treatment Options Focused on the Whole Patient

    Speaker: Greg Mattingly, MD – St.Charles Psychiatric Associates

    Speaker: Julie A. Carbray, PhD, APRN – University of Illinois Chicago

    This MasterClass session aims to equip participants with the knowledge and skills to better understand the diagnostic challenges associated with bipolar disorder (BD), including differentiating BD1, BD2, and MDD. Expert faculty will highlight the impact of cardiometabolic burden on treatment adherence and overall outcomes in patients with BD, providing practical guidance on how to mitigate these risks. Participants will also be introduced to the limitations of traditional antipsychotic agents and off-label therapies in BD, as well as the latest clinical evidence and mechanisms of action associated with newer/novel therapies. The session will conclude by evaluating the potential of these newer/novel therapies to mitigate cardiometabolic adverse effects in patients with BD, equipping participants to make informed decisions about which therapy to prescribe in individual cases.

    Click to Read More

    Master Class

  • 6:15 PM – 6:45 PM CT
    Reception
  • 6:45 PM – 7:45 PM CT
    Eric C. Arauz Memorial Keynote Address: Healing through Music: The Transformative Power of Songwriting in Mental Health

    Speaker: Christine Moutier, MD

    Dr. Christine Moutier, Chief Medical Officer of ASFP will kick off our keynote address by discussing their mission to save lives and bring hope to those affected by suicide. Following her presentation Music Neighbors will delve into the power of music as a tool for processing trauma and addressing mental health issues. Through the lens of local musicians, we will experience an iconic Nashville Songwriters' rounds, where artists will share personal stories and perform songs that have helped them to heal. By hearing from these artists, we will explore how music can provide a cathartic release, self-expression, and emotional processing. Join us for this inspiring and thought-provoking session that highlights the intersection of music and mental health.

    Developed in partnership with AFSP.